Mentor Capital owns no stock in Quantum Immunologics. Mentor, and itsw CEO, Chet Billingsley, agreed to a rescission. Last July 19, 2010, Chet cashed a check for $118, 000 from Quantum, thereby agreeing to the rescission, and returning Quantum stock to Quantum. As of today, Spet. 30, 2010, the MEntor Capital website seems to imply that Mentor still owns stock in Quantum. Chet Billingsly has not done a "Shareholders Update" on his website since may, 2010. The stockholders of Mentor Capital, Inc. (MNTR) (MNTR.PK) should know the truth about this very important matter.